Bradley Foster & Sargent Inc. CT Acquires 5,422 Shares of Synopsys, Inc. $SNPS

Bradley Foster & Sargent Inc. CT boosted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 230.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,778 shares of the semiconductor company’s stock after buying an additional 5,422 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Synopsys were worth $3,838,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Alpine Bank Wealth Management increased its holdings in shares of Synopsys by 89.3% during the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 25 shares during the last quarter. TFC Financial Management Inc. boosted its position in Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC acquired a new position in shares of Synopsys in the third quarter valued at $27,000. SOA Wealth Advisors LLC. acquired a new position in shares of Synopsys in the third quarter valued at $28,000. Finally, McIlrath & Eck LLC bought a new position in shares of Synopsys in the third quarter valued at about $29,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages recently commented on SNPS. KeyCorp lifted their target price on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Morgan Stanley restated an “overweight” rating on shares of Synopsys in a report on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Rosenblatt Securities reissued a “buy” rating and set a $560.00 price target on shares of Synopsys in a report on Friday, February 20th. Finally, The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the company a “buy” rating in a research note on Wednesday. Nine analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $547.00.

Synopsys Stock Performance

Shares of Synopsys stock opened at $449.17 on Thursday. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The company has a market cap of $86.04 billion, a PE ratio of 56.22, a price-to-earnings-growth ratio of 3.67 and a beta of 1.12. The company has a 50 day moving average of $472.85 and a 200-day moving average of $479.02. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating the consensus estimate of $3.56 by $0.21. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.41 billion during the quarter, compared to the consensus estimate of $2.39 billion. During the same period in the previous year, the business earned $3.03 earnings per share. The company’s revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities research analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Q1 beat and strong results — Synopsys reported non‑GAAP EPS of $3.77 and revenue of $2.409B, topping estimates and showing strong year‑over‑year growth; the quarter came at the high end of prior guidance. PR Newswire: Q1 Results
• Positive Sentiment: Very bullish guidance — management raised FY26 EPS guidance to $14.38–$14.46 and Q2 EPS guidance to $3.11–$3.17, well above Street estimates, which is driving optimism about near‑term earnings power. Guidance/Press Release
• Positive Sentiment: Capital return boost — the board authorized up to $2.0B in additional share repurchases, which supports EPS and signals confidence from management. Buyback Announcement
• Positive Sentiment: Analyst and market interest — Morgan Stanley reiterated a Buy and noted strong earnings quality and IP trajectory; unusual call‑option buying also points to bullish trader positioning. TipRanks: Morgan Stanley Buy
• Neutral Sentiment: Mixed near‑term revenue signal — while EPS guidance was raised, quarterly revenue guidance landed roughly in line with expectations, suggesting upside is currently EPS‑driven rather than revenue surprise. Guidance Details
• Negative Sentiment: China export restrictions and muted next‑quarter outlook — Reuters flagged Synopsys forecasting a more muted quarter amid China export limits and macro uncertainty, which pressured the stock earlier and could cap upside if geopolitical risk persists. Reuters: China Export Restrictions
• Negative Sentiment: Leverage concerns from M&A — commentators note Synopsys carries large incremental debt (post‑deal) that investors are watching closely; higher leverage raises sensitivity to execution and could limit valuation expansion. 24/7 Wall St.: Debt Concerns

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Janet Lee sold 250 shares of the stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This trade represents a 2.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 in the last three months. 0.62% of the stock is owned by insiders.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.